Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 SEP 21 ... (Vitamin A), U.S. Fund for Unicef. This article was prepared by AIDS Vaccine Week editors from staff and other reports. Copyright 2009, AIDS Vaccine Week via ...
2009 SEP 21 ... attenuated vaccines don't always work. It also suggests ways to engineer an attenuated vaccine to make it as potent as a live vaccine but as safe as a killed vaccine. ...
2009 SEP 28 ... United Kingdom, "Infection of the mouse central nervous system with wild type (WT) and vaccine strains of measles virus (MV) results in lack of clinical signs and limited antigen ...
2009 NOV 16 ... (pneumococcal disease) and Haemophilus influenzae type b (Hib). However, use of Hib vaccine has only recently expanded to low-income countries and pneumococcal vaccine is not yet ...
Subject: The Global Coalition against Child Pneumonia
2009 OCT 6 ... children For each Dot sold, the Superpremio Ltd. will donate to UNICEF one vaccine against measles. Did you know: "Measles kills more than 600 children every ...
2009 OCT 19 ... therapeutics for HIV, VHF and CMV; studies assessing anti-PS antibodies as vaccines or vaccine adjuvants for the prevention of HIV and other infectious diseases; and studies of ...
2009 OCT 6 ... region, practice, and calendar time. The effect of the measles, mumps, and rubella (MMR) vaccine was estimated by comparing vaccine exposure of those diagnosed with mumps and those who ...
2009 SEP 21 ... high containment facilities, and will provide a valuable tool for basic research and vaccine development. ." Tamin and colleagues published their study in the Journal ...
2009 SEP 21 ... report. "This may be due to incomplete routine administration of MMR vaccine in infancy and a build-up of susceptible females reaching the childbearing age group who ...
2009 OCT 12 ... from the United States following the introduction of an efficacious live-attenuated vaccine in 1969, a small proportion of the population remains susceptible." ...
2009 OCT 19 ... "The widely used hepatitis B virus (HBV) vaccine is based on three doses of hepatitis B surface antigen (HBsAg) protein," investigators ...
2009 OCT 19 ... titer could be examined, together with disease and vaccination histories. Live measles vaccine was administered to 42 children with negative antibody titer. The antibody ...
2009 NOV 9 ... Virology, McGill University. This article was prepared by AIDS Vaccine Week editors from staff and other reports. Copyright 2009, AIDS Vaccine Week via ...
2009 OCT 19 ... titer could be examined, together with disease and vaccination histories. Live measles vaccine was administered to 42 children with negative antibody titer. The antibody ...
2009 NOV 16 ... conjugate vaccine (MCV4) at 9 months of age and then MCV4 concomitantly with the measles-mumps-rubella vaccine (MMRV), pneumococcal conjugate vaccine (PCV7), and a Hepatitis A (HepA) vaccine at 12 ...
2009 SEP 21 ... from Kuala Lumpur, Malaysia, "In Malaysia, the two dose measles - mumps - rubella (MMR) vaccine was introduced in the Expanded Program on Immunization in 2002. The Ministry of Health ...
2009 NOV 16 ... the Centers for Disease Control and Prevention. The first waves of H1N1 vaccine will be allocated to states in proportion to population. Immunization is recommended ...
2009 NOV 9 ... rates. Presently, only about 40 percent of teenage girls receive the first dose of HPV vaccine with fewer than 20 percent receiving the complete three-dose series. Committee members ...
2009 SEP 28 ... that operates like a business, but with a not-for-profit operating model, to address the vaccine needs of low-income countries. As well as developing new vaccines in areas of unmet ...
